MedPath

Vibrotactile Coordinated Reset for Spasticity After Spinal Cord Injury

Not Applicable
Not yet recruiting
Conditions
Spinal Cord Injuries
Spasticity, Muscle
Interventions
Device: Vibrotactile Coordinated Reset
Registration Number
NCT06290609
Lead Sponsor
Stanford University
Brief Summary

The purpose of our study is to evaluate vibrotactile Coordinated Reset (vCR) and its effects on spasticity symptoms in incomplete spinal cord injured patients. vCR will be administered with a device called the Stanford CR Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as oral baclofen and or deep brain stimulation. Patients will be followed for three months and will be asked to come to the lab for clinical testing 4 times during this period. A total of 30 patients will be included in the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Age at the time of enrollment: Any adult ages 18 and over
  2. Spinal Cord Injury: ASIA C or D injury at level C1-T1
  3. Duration of incomplete spinal cord injury minimum 1 years clinical/fundamental
  4. Spasticity with a of MAS score >3 present in upper extremities.
  5. Fluent in English
  6. If patient is on medication that affects brain function or alters EEG activity, the patient must feel comfortable going off this medication prior to EEG recording.
  7. Appropriate social support if required during an off-medication state.
  8. Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
  9. Feels comfortable going off certain spasticity related medication during in-person study visits
  10. Lives in the United States
Exclusion Criteria
  1. Sensory deficits in palma manus resulting in missing inter digit discrimination of the fingertips.
  2. Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies.
  3. Any current drug or alcohol abuse.
  4. Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  5. Pregnancy, breast-feeding or wanting to become pregnant.
  6. Physical limitations unrelated to spasticity that would affect motor ratings.
  7. Craniotomy
  8. Brain surgery
  9. Patient is unable to communicate properly with staff (i.e., severe speech problems)
  10. Medications that may affect relevant synaptic plasticity
  11. Concurrent Botox treatment
  12. A type of hairstyle that would impede the use of an EEG cap.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Vibrotactile Coordinated Reset stimulationVibrotactile Coordinated ResetParticipants will receive vCR stimulation, involving vibratory stimulation of the fingertips, with the Stanford CR Glove on a daily or weekly basis.
Primary Outcome Measures
NameTimeMethod
Change from baseline in spasticity with the Modified Ashworth Scale (MAS) at 2 hours, 1 week, 4 weeks, and 12 weeks.Baseline, 2 hours, 1 week, 4 weeks, and 12 weeks

The MAS is a method of grading muscle spasticity according to a 6-point ordinal scale. In this assessment, spasticity is judged to be present when resistance is encountered during passive muscle stretching. With a score of 0 indicating no increase in muscle flexion and a score on 4 indicating and increase in muscle flexion. Low numeric ratings indicate better outcomes and high numbers indicate worse outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath